High basal levels of lnc-EGFR specifically bind to EGFR in HCC patients, blocking its interaction and ubiquitination with c-CBL, stabilizing it and enhancing its own and downstream activation of the AP-1/NF-AT1 axis. This evidence concerns the gene EGFR and hepatocellular carcinoma.